01 1Shandong Anhong Pharmaceutical
01 1NINTEDANIB ESYLATE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-06-14
Pay. Date : 2023-04-24
DMF Number : 38298
Submission : 2023-04-28
Status : Active
Type : II
20
Shandong Anhong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is NINTEDANIB ESYLATE, with a corresponding US DMF Number 38298.
Remarkably, this DMF maintains an Active status since its submission on April 28, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 14, 2023, and payment made on April 24, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
